# ATROPINE SULFATE
> **ANDA215005** · Abbreviated New Drug Application (Generic) · Sponsor: SOMERSET THERAPS LLC · Approved 2024-11-29
## Drug
- **FDA Application Number:** ANDA215005
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ATROPINE SULFATE
- **Generic name:** ATROPINE SULFATE MONOHYDRATE
- **Active ingredients:** ATROPINE SULFATE
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS, INTRAMUSCULAR, SUBCUTANEOUS, INTRAOSSEOUS, ENDOTRACHEAL
- **Marketing status:** Prescription
- **Sponsor:** SOMERSET THERAPS LLC
- **Manufacturer:** Somerset Therapeutics, LLC
- **First approval:** 2024-11-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215005)
---
*AI Analytics · CC0 1.0*